Pardeep Nijhawan is CEO & 10% Owner at Edesa Biotech, Inc. (EDSA). They have made 18 open-market trades across 1 company since 2021, most recently 2026-10-05.
CIK 0001777962
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
18 open-market purchases totalling $363K since 2021, never a sale. Across 18 scored buys the stock is up 1.7% at ninety days, and 2.0 points ahead of the S&P over the same stretch.
18 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| EDSA | 905,993 | $2.3M |
Shares reported on the most recent Form 4, priced at the 2026-10-06 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 67% | 44% | 50% |
| Avg Move | +18.4% | +6.2% | +1.7% |
| Alpha | +18.0% | +7.6% | +2.0% |
| Scored | 18 | 18 | 18 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EDSA | BUY | 2026-03-10 | 2026-03-10 | $6.60 | $7K | +10.2% | -10.5% | -20.5% |
| EDSA | BUY | 2026-03-05 | 2026-03-06 | $3.90 | $39K | +22.1% | -7.8% | +13.5% |
| EDSA | BUY | 2026-03-04 | 2026-03-05 | $4.26 | $43K | +92.3% | +59.6% | +88.9% |
| EDSA | BUY | 2026-03-03 | 2026-03-04 | $3.63 | $36K | +17.7% | +33.6% | +57.7% |
| EDSA | BUY | 2026-03-02 | 2026-03-03 | $2.09 | $6K | +30.6% | +34.5% | +46.4% |
| EDSA | BUY | 2026-02-26 | 2026-03-02 | $1.96 | $99K | +155.2% | +122.0% | +167.4% |
| EDSA | BUY | 2024-03-25 | 2024-03-25 | $4.00 | $20K | +11.7% | +3.0% | +4.5% |
| EDSA | BUY | 2022-05-27 | 2022-05-31 | $1.92 | $10K | -11.2% | -24.8% | -11.2% |
| EDSA | BUY | 2022-05-24 | 2022-05-25 | $1.80 | $4K | +13.9% | -5.8% | +5.2% |
| EDSA | BUY | 2022-03-30 | 2022-03-31 | $3.05 | $6K | -10.9% | -29.1% | -51.0% |
| EDSA | BUY | 2022-03-29 | 2022-03-30 | $3.02 | $6K | -4.1% | -23.7% | -49.5% |
| EDSA | BUY | 2022-03-18 | 2022-03-21 | $3.85 | $8K | -10.0% | -19.1% | -50.0% |
| EDSA | BUY | 2022-03-17 | 2022-03-18 | $3.26 | $7K | -24.2% | -26.2% | -58.0% |
| EDSA | BUY | 2022-03-15 | 2022-03-16 | $2.80 | $6K | -8.1% | -9.4% | -47.2% |
| EDSA | BUY | 2022-03-11 | 2022-03-14 | $3.09 | $22K | +23.2% | +4.1% | -36.9% |
| EDSA | BUY | 2022-03-09 | 2022-03-10 | $3.05 | $5K | +8.0% | -10.9% | -36.4% |
| EDSA | BUY | 2021-03-25 | 2021-03-26 | $5.25 | $16K | +8.4% | +11.1% | +5.0% |
| EDSA | BUY | 2021-03-24 | 2021-03-25 | $5.16 | $26K | +7.1% | +10.9% | +3.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.